Guidelines for ATC classification and DDD assignment - WHOCC

The DDDs in this group are based on treatment of luminal
amoebiasis.
P01AR Arsenic compounds
This group comprises e.g. glycobiarsol. Combinations containing
clioquinol are classified in P01AA.
P01AX Other agents against amoebiasis and other protozoal diseases
This group comprises agents, which cannot be classified in the
preceding groups. Combinations with clioquinol are classified in
P01AA.
P01B ANTIMALARIALS
This group comprises drugs mainly used for treatment and prophylaxis
of malaria.
The DDDs are based on the treatment of malaria, except for
proguanil, which is used for prophylaxis only. For some substances
the DDDs are expressed as amount of base. These are indicated in
the ATC index.
P01BA Aminoquinolines
Combinations with clioquinol are classified in P01AA. Combinations
with glycobiarsol are classified in P01AR.
P01BB Biguanides
The DDDs are based on the average daily dose for the treatment
period.
The DDD for proguanil is based on the daily dose given for
prophylaxis of malaria. The DDD for proguanil, combinations is
based on treatment of acute malaria, see list of DDDs for
combination products www.whocc.no.
227